White Papers related to Regulatory Writing / Scientific and Technical Writing

White Paper
This paper gives details on the background and recommended steps required to ensure your medicinal products comply with the latest guidance for nitrosamines.
Scroll to Top

Suspicious Emails

We are aware of a number of suspicious emails about recruitment in circulation purporting to be from PharmaLex. Emails sent by PharmaLex will originate from @pharmalex.com. Should you receive an email and are unsure as to its validity, please report it to contact@pharmalex.com.

Many thanks for your understanding.

The PharmaLex Team